Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
HuBei NengTer Technology CO.,Ltd (002102.SZ)
Quanzhou, CN
Guanfu Holding Co., Ltd. operates an e-commerce platform within China, primarily specializing in the online procurement of plastic raw materials. Additionally, the company is deeply involved in the pharmaceutical industry, undertaking the research, development, manufacturing, and distribution of both pharmaceutical intermediates and vitamin E. Its business operations are further diversified to include real estate leasing and gold mining activities. Established in 1989, the company, headquartered in Quanzhou, China, was formerly recognized as Fujian Guanfu Modern Household Wares Co., Ltd. before officially adopting its current name, Guanfu Holding Co., Ltd., in August 2016.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.98% | -0.85% | -16.85% | -34.46% | -35.73% | -30.33% | -28.83% | -35.20% | +4.50% | -38.41% | +86.76% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-40.8% Q1'26: -47.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+144.3% ★ Q1'26: -88.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-2.7% Q1'26: -14.4% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+4.0% Q1'26: +2.4% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+8.6% ★ Q1'26: +4.6% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-4.7% ★ Q1'26: -6.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.46× ★ Q1'26: 7.47× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
14.29B
est: 2.57B (+457.0%)
|
13.53B
est: 8.44B (+60.4%)
|
12.26B
est: 12.02B (+2.0%)
|
11.13B
est: 15.54B (-28.4%)
|
7.27B
est: 10.10B (-28.0%)
|
7.47B
7.47B – 7.47B
-26.0% YoY
|
2.07B
2.07B – 2.07B
-72.2% YoY
|
| EBITDA |
-1.05B
est: 53.00M (-2,090.1%)
|
330.41M
est: 174.26M (+89.6%)
|
288.32M
est: 248.32M (+16.1%)
|
227.05M
est: 321.08M (-29.3%)
|
437.33M
est: 283.08M (+54.5%)
|
209.43M
209.43M – 209.43M
-26.0% YoY
|
58.14M
58.14M – 58.14M
-72.2% YoY
|
| EBIT |
-1.17B
est: 28.41M (-4,202.2%)
|
231.11M
est: 93.41M (+147.4%)
|
154.83M
est: 133.11M (+16.3%)
|
88.69M
est: 172.11M (-48.5%)
|
293.12M
est: 157.99M (+85.5%)
|
116.89M
116.89M – 116.89M
-26.0% YoY
|
32.45M
32.45M – 32.45M
-72.2% YoY
|
| Net Income |
-2.71B
|
101.09M
est: 316.00M (-68.0%)
|
444.48M
est: 763.68M (-41.8%)
|
258.74M
est: 816.34M (-68.3%)
|
248.45M
est: 652.50M (-61.9%)
|
777.98M
777.98M – 777.98M
+19.2% YoY
|
878.37M
878.37M – 878.37M
+12.9% YoY
|
| SGA |
157.86M
est: 23.80M (+563.4%)
|
134.61M
est: 78.24M (+72.1%)
|
110.19M
est: 111.49M (-1.2%)
|
94.56M
est: 144.15M (-34.4%)
|
31.60M
est: 80.34M (-60.7%)
|
59.44M
59.44M – 59.44M
-26.0% YoY
|
16.50M
16.50M – 16.50M
-72.2% YoY
|
| EPS |
-1.03
|
0.04
est: 0.12 (-68.0%)
|
0.17
est: 0.29 (-41.8%)
|
0.10
est: 0.31 (-68.3%)
|
0.10
est: 0.26 (-61.9%)
|
0.31
0.31 – 0.31
+19.2% YoY
|
0.35
0.35 – 0.35
+12.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-28 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-25 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dan Jian | Financial Director | — | female |
| Haixiong Deng | Vice Chairman & GM | — | male |
| Hao Huang | Secretary of the Board of Directors & Non-Independent Director | — | male |
| Wen Qing Zhang | Accounting Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002102.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
